Search alternatives:
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i wt » _ wt (Expand Search), i w (Expand Search), i et (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i wt » _ wt (Expand Search), i w (Expand Search), i et (Expand Search)
-
13621
miR-34a-5p is the direct target of SNHG17; miR-34a-5p inhibitor reverses the inhibitory effect of SNHG17 knockdown on lymphoma cells.
Published 2023“…(G) Expression of miR-34a-5p decreased in lymphoma cells and was negatively correlated with SNHG17. …”
-
13622
The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation
Published 2017“…Especially the loss of apical RAI3 expression represents an independent prognostic parameter for overall survival of patients with pancreatic cancer. Suppression of GPRC5a results in decreased cell growth, proliferation and migration in pancreatic cancer cell lines via a STAT3 modulated pathway, independent from ERK activation.…”
-
13623
-
13624
H<sub>2</sub>O<sub>2</sub> decreased PC12 cells viability.
Published 2013“…<p>MTT assay showed that 12.5∼25 µM H<sub>2</sub>O<sub>2</sub> treatment had no obvious effect, while 50 µM, 100 µM, and 200 µM H<sub>2</sub>O<sub>2</sub> treatment resulted in cell viability decrease by 7%, 15% and 16%, respectively. …”
-
13625
-
13626
-
13627
-
13628
-
13629
-
13630
-
13631
-
13632
-
13633
-
13634
-
13635
-
13636
<i>N</i>‑2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX‑2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression
Published 2022“…In vivo, <b>1H-30</b> showed acceptable pharmacokinetic parameters, decreased the tumor growth without affecting the body weight, down-regulated COX-2 and MMP-9, and induced apoptosis in the CT26.WT tumor-bearing mice. …”
-
13637
<i>N</i>‑2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX‑2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression
Published 2022“…In vivo, <b>1H-30</b> showed acceptable pharmacokinetic parameters, decreased the tumor growth without affecting the body weight, down-regulated COX-2 and MMP-9, and induced apoptosis in the CT26.WT tumor-bearing mice. …”
-
13638
<i>N</i>‑2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX‑2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression
Published 2022“…In vivo, <b>1H-30</b> showed acceptable pharmacokinetic parameters, decreased the tumor growth without affecting the body weight, down-regulated COX-2 and MMP-9, and induced apoptosis in the CT26.WT tumor-bearing mice. …”
-
13639
-
13640